Experienced in Lymphofollicular Hyperplasia

Dr. Jessica A. Thomes-Pepin

Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Minnesota Oncology Hematology PA
6025 Lake Rd, Suite 110, 
Woodbury, MN 
Accepting New Patients
16 Years of Experience
Experienced in Lymphofollicular Hyperplasia
Minnesota Oncology Hematology PA
6025 Lake Rd, Suite 110, 
Woodbury, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jessica Thomes-Pepin is a Gynecologic Oncologist and an Oncologist in Woodbury, Minnesota. Dr. Thomes-Pepin has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Sertoli-Leydig Cell Tumor, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Endometrial Cancer, and Bladder Reconstruction. Dr. Thomes-Pepin is currently accepting new patients.

Her clinical research consists of co-authoring 8 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
2009
Specialties
Gynecologic Oncology
Oncology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in MN
Hospital Affiliations
Allina United Hospital
M Health Fairview Woodwinds Hospital
Abbott Northwestern Hospital
M Health Fairview St John's Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

MINNESOTA ONCOLOGY HEMATOLOGY PA
6025 Lake Rd, Suite 110, Woodbury, MN 55125
Other Locations
NOVACARE OUTPATIENT REHABILITATION EAST, INC.
480 Hwy 96 E, Suite 120, Vadnais Heights, MN 55127

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Tisotumab Vedotin, Topotecan, Vinorelbine, Gemcitabine, Irinotecan, Pemetrexed
Study Phase: Phase 3
MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
Enrollment Status: Completed
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drugs: Mirvetuximab Soravtansine, Paclitaxel, Topotecan, Pegylated liposomal doxorubicin
Study Phase: Phase 3
ENGOT-ov50 / GOG-3029 / INNOVATE-3: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer
ENGOT-ov50 / GOG-3029 / INNOVATE-3: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer
Enrollment Status: Completed
Publish Date: March 29, 2024
Intervention Type: Device, Drug
Study Drug: Paclitaxel
Study Phase: Phase 3
A Phase II Open-Label Study of NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
A Phase II Open-Label Study of NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Enrollment Status: Terminated
Publish Date: February 21, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

2 Total Publications

Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy.
Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 24, 2024
Similar Doctors
Advanced in Lymphofollicular Hyperplasia
Dr. Arvind Y. Vemula
Oncology | Hematology Oncology | Hematology
Advanced in Lymphofollicular Hyperplasia
Dr. Arvind Y. Vemula
Oncology | Hematology Oncology | Hematology

North Memorial Health Care

3435 W Broadway Ave, 
Robbinsdale, MN 
 (18.1 miles away)
763-581-2800
Languages Spoken:
English, Hindi, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Arvind Vemula is an Oncologist and a Hematologist Oncology provider in Robbinsdale, Minnesota. Dr. Vemula is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are POEMS Syndrome, Lung Cancer, Pleuropulmonary Blastoma, Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Vemula is currently accepting new patients.

Advanced in Lymphofollicular Hyperplasia
Dr. Avina K. Singh
Hematology Oncology | Oncology | Hematology
Advanced in Lymphofollicular Hyperplasia
Dr. Avina K. Singh
Hematology Oncology | Oncology | Hematology

Minnesota Oncology Hematology PA

675 E Nicollet Blvd, Suite 100, 
Burnsville, MN 
 (18.0 miles away)
952-892-7190
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Avina Singh is a Hematologist Oncology specialist and an Oncologist in Burnsville, Minnesota. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Chronic Lymphocytic Leukemia (CLL), and Pleuropulmonary Blastoma. Dr. Singh is currently accepting new patients.

Advanced in Lymphofollicular Hyperplasia
Dr. Robert Delaune
Hematology Oncology | Oncology | Hematology
Advanced in Lymphofollicular Hyperplasia
Dr. Robert Delaune
Hematology Oncology | Oncology | Hematology

Minnesota Oncology Hematology PA

1580 Beam Ave, 
Maplewood, MN 
 (8.0 miles away)
651-779-7978
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Delaune is a Hematologist Oncology specialist and an Oncologist in Maplewood, Minnesota. Dr. Delaune is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Follicular Lymphoma, and Severe Congenital Neutropenia. Dr. Delaune is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Thomes-Pepin's expertise for a condition
ConditionClose
    View All 12 Distinguished Conditions
    View All 45 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile